Search

Your search keyword '"Wu, Y-L"' showing total 1,899 results

Search Constraints

Start Over You searched for: Author "Wu, Y-L" Remove constraint Author: "Wu, Y-L"
1,899 results on '"Wu, Y-L"'

Search Results

2. On structure of topological entropy for tree-shift of finite type

4. Ultrafast Quasiparticle Dynamics and Electron-Phonon Coupling in (Li0.84Fe0.16)OHFe0.98Se

6. Strong Pseudospin-Lattice Coupling in Sr3Ir2O7: Coherent Phonon Anomaly and Negative Thermal Expansion

9. Ultrafast Dynamics Evidence of High Temperature Superconductivity in Single Unit Cell FeSe on SrTiO3

10. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis

12. Diffraction-limited Visible Light Images of Orion Trapezium Cluster With the Magellan Adaptive Secondary AO System (MagAO)

13. High Resolution H alpha Images of the Binary Low-mass Proplyd LV 1 with the Magellan AO System

15. Anomalous Silicate Dust Emission in the Type 1 LINER Nucleus of M81

17. 44P Exploratory analysis of peripheral pharmacodynamic (PD) biomarkers after sitravatinib (Sitra) and tislelizumab (TIS) in advanced solid tumors: SAFFRON-103

18. WS02.13 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)

22. P2.04-03 EGRET: First-in-human Study of the Novel Antibody-drug Conjugate AZD9592 ± Anti-cancer Agents in Advanced Solid Tumours

28. P1.27-03 Neoadjuvant PD-1 Blockade Plus Platinum-based Chemotherapy for EGFR-mutant NSCLC (CTONG2104): An Interim Analysis

29. P2.06-07 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)

31. OA21.05 Tepotinib + Osimertinib in EGFR-mutant NSCLC with MET Amplification Following 1L Osimertinib: INSIGHT 2 Primary Analysis

32. P1.23-09 Cerebrospinal Fluid ctDNA Based Therapy Associated with Survival of CNS Metastases in Advanced NSCLC: A Large Scale, Comprehensive Study

35. P1.09-02 Midkine Dependent Immunosuppressive Environment in Cerebrospinal Fluid May Promote Leptomeningeal Metastases of EGFR mutant NSCLC

36. Physics at BES-III

37. Exclusive $B \to PV $ Decays and CP Violation in the General two-Higgs-doublet Model

39. 1/m_Q Corrections to B -> rho l nu Decay and |V_{ub}

42. B Physics and Hadronic Matrix Elements

43. Lifetime Difference and Endpoint effect in the Inclusive Bottom Hadron Decays

44. A More Precise Extraction of |V_{cb}| in HQEFT of QCD

45. 1/m_Q order contributions to B \to \pi l \nu decay in HQEFT

46. The Effects of Relativistic Corrections on Cosmological Parameter Estimations from SZE Cluster Surveys

47. HQEFT as A Large Component QCD and Comments on The Incompleteness of HQET

48. Exclusive B-meson Rare Decays and General Relations of Form Factors in Effective Field Theory of Heavy Quarks

49. Heavy to Light Meson Exclusive Semileptonic Decays in Effective Field Theory of Heavy Quark

50. V_{ub}, V_{cb} and Decay Constants in Effective Field Theory of Heavy Quarks

Catalog

Books, media, physical & digital resources